The AACR is hosting its Ninth Annual Frontiers in Cancer Prevention Research Conference Nov. 7-10, 2010 at the Pennsylvania Convention Center in Philadelphia.
Experts estimate that nearly half of all cancers can be prevented based on what we know about smoking cessation, healthy lifestyles and the emerging science of chemoprevention. This annual conference is a one-of-a-kind meeting that draws hundreds of physicians, scientists and other health professionals and promotes public, academic, government and industry awareness of the vital importance of cancer prevention science in reducing cancer incidence and mortality. The theme of this year's conference is Prevention: From Basic Science to Public Health Benefit.
The AACR will host three media conferences and several interviews with selected speakers which will be posted here as soon as possible after the events:
Prevention 2010: Interview with Judy E. Garber, M.D., M.P.H., AACR president-elect, senior editor of Cancer Prevention Research, and leader of the center for cancer genetics and prevention at Dana-Farber Cancer Institute
Dr. Garber talks to the AACR about the promise of PARP inhibitors in women with BRCA 1 and 2 mutations who have advanced ovarian and breast cancers.
Prevention 2010: Interview with Eva Szabo, M.D., chief of the Lung and Upper Aerodigestive Cancer Research Group in the Division of Cancer Prevention at the National Cancer Institute and chair of the Scientific Program Committee for the Frontiers in Cancer Prevention Research Conference
Dr. Szabo talks about PPAR gamma as a target for aerodigestive cancer prevention, clinical trials and barriers that exist in clinical trial participation for prevention vs. treatment trials.
Prevention 2010: Interview with Raymond N. DuBois, M.D., Ph.D., provost and executive vice-president of the University of Texas MD Anderson Cancer Center
Dr. DuBois discusses the challenges of cancer prevention as a public health issue, the scientific priorities for the next Stand Up To Cancer dream teams and the opportunities for the AACR in the areas of clinical and translational research.
Prevention 2010: Interview with Powel H. Brown, M.D., Ph.D., professor and chairman of the department of clinical cancer prevention at the University of Texas MD Anderson Cancer Center
In this podcast, Dr. Brown discusses the early detection of breast cancer, the effects of hormones and growth factors on gene expression and external risk factors for breast cancer.
Prevention 2010: Interview with John D. Groopman, Ph.D., chair of the department of environmental health sciences, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University; recipient of the 2010 AACR-Prevent Cancer Foundation Award for Excellence in Cancer Prevention Research
Dr. Groopman talks about his landmark work in the field of hepatocellular carcinoma and the role of aflotoxins in the induction of this devastating liver cancer.
Prevention 2010: Interview with Avrum E. Spira, M.D., M.Sc., chief, division of computational biomedicine and director of the translational bioinformatics program at Boston University’s Clinical and Translational Science Institute
Dr. Spira discusses his presentation, “Identifying the Smoker at Risk for Lung Cancer,” and what he calls a molecular “field of injury.” He also talks about personalized genomic approaches to lung cancer treatment for smokers at high risk for lung cancer.
Prevention 2010: Interview with Kathryn L. Taylor, Ph.D., associate professor at Georgetown’s Lombardi Comprehensive Cancer Center
Dr. Taylor discusses the latest research in early prostate cancer diagnosis and treatment, disease-related mortality, over-diagnosis and the challenges of educating men about the benefits and limitations of screening.
Prevention 2010: Interview with Scott M. Lippman, M.D., chair of the department of thoracic/head and neck medical oncology at the University of Texas M D Anderson Cancer Center and editor-in-chief of one of the AACR’s journals, Cancer Prevention Research
Dr. Lippman covers a wide range of topics in this podcast including “personalized prevention” and the increased need for collaboration among basic, clinical, translational and prevention researchers.
Prevention 2010: Interview with Elizabeth H. Blackburn, Ph.D., AACR president, 2009 Nobel Prize in Medicine or Physiology recipient, Morris Herzstein professor of biology and physiology in the department of biochemistry and biophysics at the University of California, San Francisco
Keynote speaker Dr. Blackburn talks about her lecture, "Telomere Biology and Cancer," and the implications of basic science research, an example being telomeres, for cancer prevention. She also discusses the need for increased attention to prevention and her concept of "cancer interception."
Prevention 2010: Interview with Curtis C. Harris, M.D., chief of the laboratory of human carcinogenesis at the National Institutes of Health
Dr. Harris discusses the topic of his distinguished lecture, inflammation and cancer and the role of infection and chronic inflammation in cancer development.
Prevention 2010: Interview with Mary E. Reid, Ph.D., associate professor of oncology and director of collaborative research, Roswell Park Cancer Institute
In this podcast, Dr. Reid discusses fluorescent screening for lung and head and neck cancers, ongoing cancer clinical trials in lung cancer prevention, and her involvement in an international registry of premalignant lesions of the lung.
Prevention 2010: Interview with John Carpten, Ph.D., senior investigator and director of the Integrated Cancer Genomics Division of TGen (Translational Genomics Research Institute), Phoenix, AZ
In this audio interview, Dr. Carpten discusses the latest genetic technology that can be used for various tumors, the potential for new treatments for many types of cancer and the African-American Hereditary Prostate Cancer Study Network.
"The Emerging Science of Chemoprevention"
Monday, Nov. 8 at 12:30 p.m. ET
Moderated by Scott Lippman, M.D., editor-in-chief of Cancer Prevention Research and professor and chair in the department of thoracic head and neck medical oncology at The University of Texas M D Anderson Cancer Center
"Cancer Prevention Among Women"
Tuesday, Nov. 9, at 12:00 p.m. ET
Moderated by Judy Garber, M.D., M.P.H., president-elect of the American Association for Cancer Research and leader of the Center for Cancer Genetics and Prevention at the Dana-Farber Cancer Institute
"Results of the National Lung Cancer Screening Trial"
Tuesday, Nov. 9 at 2:00 p.m. ET
Listen to this press conference with Christine Berg, M.D., of the Early Detection Research Group at the National Cancer Institute, who presented the initial results of the National Lung Cancer Screening Trial at AACR's Frontiers in Cancer Prevention Research Conference.
Check back frequently to stay up-to-date or subscribe to the AACR Scientific Podcasts feed through the following:
Subscribe to the AACR Scientific Podcasts via an RSS Reader.
Follow AACR on Twitter @AACR and throughout the meeting using the hash tag #AACR
Subscribe to the AACR RSS News Feed
Updated: November 10, 2010